Rafferty Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
|
|||||
|
2025
Q1 | $964K | Sell |
|
|||||
|
2024
Q4 | $1.27M | Buy |
|
|||||
|
2024
Q3 | $1.28M | Sell |
|
|||||
|
2024
Q2 | $1.45M | Buy |
|
|||||
|
2024
Q1 | $1.88M | Buy |
|
|||||
|
2023
Q4 | $1.23M | Sell |
|
|||||
|
2023
Q3 | $1.05M | Buy |
|
|||||
|
2023
Q2 | $1.04M | Buy |
|
|||||
|
2023
Q1 | $919K | Sell |
|
|||||
|
2022
Q4 | $1.29M | Buy |
|
|||||
|
2022
Q3 | $969K | Buy |
|
|||||
|
2022
Q2 | $264K | Sell |
|
|||||
|
2022
Q1 | $438K | Sell |
|
|||||
|
2021
Q4 | $639K | Buy |
|
|||||
|
2021
Q3 | $663K | Buy |
|
|||||
|
2021
Q2 | $385K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $612K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $553K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $303K | Buy |
|